IFM2017-03: Dara Len in Frail ND MM
IFM2017-03: Phase III Trial of Daratumumab Plus Lenalidomide Without Long-term Dexamethasone vs Lenalidomide and Dexamethasone in Frail Patients With Newly Diagnosed MM

Released: December 12, 2024

Expiration: December 11, 2025

Activity

Progress
1
Course Completed